virus

U of M COVID-19 Clinical Trial Expands Participant Enrollment Opportunities

April 1, 2020

This trial is testing hydroxychloroquine, an FDA-approved medicine for the prevention and treatment of malaria. This is the first clinical trial to determine if hydroxychloroquine is effective in preventing COVID-19 in humans.

Other News

planting
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
connections
I’m young and healthy, why should I get vaccinated? In the United States, we have a long history of helping each other. If a river is…
mask and vaccine
 We’re a month away from the start of classes for the 2021/22 Academic Year and I believe we are all looking forward to seeing colleagues…